Weight loss drugs could cost Medicare $6B a year: Study

(By Rylee Wilson for Becker’s Hospital Review)

Medicare spending could increase between $3.1 billion and $6.1 billion annually if the program covers GLP-1 drugs for weight loss, a study published Aug. 15 in Health Affairs found.

Under current law, Medicare cannot pay for any drug prescribed solely for weight loss. Continue reading here…

Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.